Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome

Scandinavian Journal of Immunology

Volumn 54, Issue 1-2, 2001, Pages 55-61

  Magnusson, V ^a   Nakken, B ^b   Bolstad, A I ^a,c   Alarcon Riquelme M E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034963122     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00965.x     Document Type: Review

References (76)

1. Systemic lupus erythematosus: Demographics, prognosis, and outcome
2. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome
3. Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds
4. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
5. Immunogenetics and the cause of autoimmune disease
6. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus
7. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus
8. A polymorphic dinucleotide repeat in the human IL-10 promoter
9. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines
10. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus
11. Genetic analysis of the contribution of IL10 to systemic lupus erythematosus
12. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease
13. Association of the interferon-gamma receptor variant (Vall4Met) with systemic lupus erythematosus
14. Polymorphisms within the interleukin-10 receptor cDNA gene (IL10R) in Japanese patients with systemic lupus erythematosus
15. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils
16. Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN)
17. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
18. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene
19. Interleukin-1 receptor antagonist allele (ILIRN*2) associated with nephropathy in diabetes mellitus
20. Psoriasis and interleukin-1
21. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
22. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
23. Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus
24. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus
25. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus
26. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus
27. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily
28. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
29. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
30. Biological and clinical aspects of interleukin 6
31. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
32. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
33. A greater variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE)
34. Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC
35. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix
36. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions
37. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
38. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population
39. Highly informative typing of the human TNF locus using six adjacent polymorphic markers
40. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus
41. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha
42. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus
43. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population
44. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans
45. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
46. Polymorphism in the Tumor Necrosis Factor gene: Association with HLA-B and DR haplotypes
47. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases
48. Genetic variability at the human tumor necrosis factor loci
49. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production
50. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus. TNFB-MHC haplotypes
51. The tumor necrosis factor ligand and receptor families
52. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
53. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sibpair families
54. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families
55. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus
56. New single nucleotide polymorphisms in the coding region of human TNFR2: Association with systemic lupus erythematosus
57. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus
58. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome
59. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands
60. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome
61. Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome
62. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome
63. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome)
64. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice
65. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10
66. Structure of IL-10 and its role in autoimmune exocrinopathy
67. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome
68. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity
69. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome
70. Genetic association between interleukin - 10 Promoter region polymorphisms and primary Sjögren's syndrome
71. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis
72. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis
73. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
74. A polymorphic variation in a putative regulation box of the TNFA promoter region
75. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility